G Ciprandi Selected Research

Allergic Rhinitis

5/2021	Pidotimod as add-on therapy in patients with pollen-induced allergic rhinitis and asthma and associated respiratory infections.
1/2021	The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world "ControL'Asma" study.
1/2021	The impact of Allergic Rhinitis in clinical practice: An International Survey.
7/2018	The relevance of the Mometasone furoate nasal spray in clinical practice.
1/2017	Adjuvant treatment with a symbiotic in patients with inflammatory non-allergic rhinitis.
1/2016	Serum allergen-specific IgE, allergic rhinitis severity, and age.
1/2016	Ancillary therapy of intranasal T-LysYal® for patients with allergic, non-allergic, and mixed rhinitis.
11/2014	Resveratrol plus carboxymethyl-β-glucan may affect respiratory infections in children with allergic rhinitis.
10/2014	Serum-soluble HLA-G is associated with specific IgE in patients with allergic rhinitis and asthma.
8/2013	Methacholine bronchial challenge effects on nasal symptoms and function in patients with allergic rhinitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Ciprandi Research Topics

Disease

41	Allergic Rhinitis 05/2021 - 09/2000
30	Hypersensitivity (Allergy) 11/2020 - 01/2000
25	Asthma (Bronchial Asthma) 10/2021 - 06/2000
23	Inflammation (Inflammations) 01/2021 - 06/2000
9	Rhinitis 04/2016 - 06/2000
7	Pruritus (Itching) 11/2020 - 01/2000
7	Seasonal Allergic Rhinitis (Hay Fever) 01/2016 - 07/2002
6	Respiratory Tract Infections (Respiratory Tract Infection) 05/2021 - 11/2014
6	COVID-19 05/2021 - 11/2020
5	Hypertrophy 01/2021 - 01/2006
5	Dysbiosis 11/2020 - 11/2020
5	Rhinosinusitis 02/2017 - 03/2002
5	Nasal Obstruction 11/2011 - 06/2004
4	Infections 11/2020 - 09/2008
3	Rhinorrhea 01/2005 - 04/2001
3	Sneezing 01/2005 - 04/2001
3	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2003 - 01/2000
2	Gastroesophageal Reflux (GERD) 07/2018 - 01/2018
2	Eosinophilia 05/2016 - 01/2004
2	Acute-Phase Reaction 01/2012 - 01/2012
2	Atopic Dermatitis (Atopic Eczema) 01/2012 - 01/2011
2	Urticaria (Hives) 01/2012 - 01/2011
2	Perennial Allergic Rhinitis 06/2004 - 11/2001
1	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2021
1	Laryngopharyngeal Reflux 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 11/2020
1	Sleep Wake Disorders 11/2019
1	Otitis Media 11/2019
1	Otitis Media with Effusion 03/2019
1	Snoring 09/2018
1	Ulcer 07/2018
1	Cough 01/2018
1	Chronic Cough 01/2018
1	Dermatitis 01/2018
1	Contact Dermatitis (Eczema, Contact) 01/2018
1	Nasal Polyps (Nasal Polyp) 02/2017

Drug/Important Bio-Agent (IBA)

17	AllergensIBA 01/2021 - 01/2000
17	Immunoglobulin E (IgE)IBA 01/2021 - 09/2000
11	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 01/2007
8	CytokinesIBA 01/2013 - 03/2002
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2016 - 10/2011
5	Biomarkers (Surrogate Marker)IBA 05/2016 - 01/2012
5	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016 - 04/2001
4	Nasal SpraysIBA 01/2016 - 01/2004
4	Interleukin-4 (Interleukin 4)IBA 01/2013 - 07/2009
3	AlginatesIBA 01/2021 - 07/2018
3	MagnesiumIBA 01/2021 - 07/2018
3	Interleukin-17 (Interleukin 17)IBA 02/2015 - 09/2009
3	Pharmaceutical PreparationsIBA 10/2013 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2012
3	flunisolide (AeroBid)FDA LinkGeneric 04/2011 - 10/2007
3	Cetirizine (Zyrtec)FDA LinkGeneric 06/2004 - 09/2001
3	levocabastine (Bilina)FDA Link 01/2003 - 01/2000
2	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2021 - 01/2021
2	VitaminsIBA 01/2021 - 11/2020
2	Histamine Antagonists (Antihistamines)IBA 11/2020 - 01/2004
2	Histamine (Histamine Dihydrochloride)FDA Link 11/2020 - 04/2011
2	Therapeutic UsesIBA 10/2014 - 11/2001
2	HLA-G Antigens (HLA G)IBA 10/2014 - 10/2008
2	Methacholine Chloride (Methacholine)FDA Link 08/2013 - 06/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 04/2001
2	NeopterinIBA 08/2012 - 01/2011
2	NitritesIBA 08/2012 - 11/2011
2	Interleukin-9 (Interleukin 9)IBA 01/2012 - 04/2011
2	PTX3 proteinIBA 01/2012 - 01/2012
2	Nasal Decongestants (Decongestants)IBA 04/2009 - 01/2005
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2008 - 04/2001
2	levocetirizine FDA LinkGeneric 01/2005 - 06/2004
2	azelastine (Optivar)FDA LinkGeneric 01/2004 - 01/2003
2	Ophthalmic Solutions (Eye Drops)IBA 06/2001 - 01/2000
2	emedastine FDA Link 06/2001 - 01/2000
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2001 - 04/2001
1	pidotimodIBA 05/2021
1	XylitolIBA 05/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	LactoferrinIBA 01/2021
1	SolutionsIBA 01/2021
1	VaccinesIBA 01/2021
1	Protein SIBA 01/2021
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2021
1	AntioxidantsIBA 11/2020
1	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2019
1	nasIBA 09/2018
1	Proton Pump InhibitorsIBA 07/2018
1	AcidsIBA 07/2018
1	IodineIBA 01/2018
1	Irritants (Vesicants)IBA 01/2018
1	OligosaccharidesIBA 01/2017
1	Saline SolutionIBA 04/2016
1	ChemokinesIBA 02/2015
1	ResveratrolIBA 11/2014
1	GlucansIBA 11/2014

Therapy/Procedure

9	Therapeutics 05/2021 - 04/2001
8	Immunotherapy 11/2020 - 01/2007
5	Aftercare (After-Treatment) 01/2018 - 04/2001
2	Adenoidectomy 03/2019 - 01/2012
2	Precision Medicine 02/2017 - 01/2016
1	Nutritional Support (Artificial Feeding) 01/2021
1	Intranasal Administration 07/2018
1	Ambulatory Care (Outpatient Care) 01/2018